Please login to the form below

Not currently logged in
Email:
Password:

Kleemann joins Merck from Boehringer

Appointed head of group tax

Pharma finance veteran Sylvia Kleemann is to leave Boehringer Ingelheim to join rival German pharma firm Merck KGaA as head of group tax at the beginning of 2014.

Kleeman served as head of corporate tax at Boehringer and has additional life sciences experience at KPMG, Celanese and Fresenius Medical Care.

In her new role, she will report to chief financial officer Matthias Zachert. She replaces Armin Gembruch who has been head of group tax since May 2011.

Zachert said: “Sylvia Kleemann has extensive experience in both the pharmaceutical and the chemical industries. At the same time, Sylvia Kleemann has a very broad understanding of both public and family-owned companies, which makes her ideally suited for her new position at Merck.”

3rd December 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics